All about Drugs Live by Dr Anthony Melvin Crasto
ROCKVILLE, Md., Sept. 22, 2016 /PRNewswire/ — Sanaria Inc. today announced it has received U.S. Food and Drug Administration (FDA) Fast Track designation for its preventative vaccine for malaria, Sanaria® PfSPZ Vaccine. Sanaria believes its PfSPZ Vaccine is the only malaria vaccine to have ever received this distinction. According to the FDA, “Fast Track is a …
DDD 107498, DDD 498 PATENT WO 2013153357, US2015045354 6-Fluoro-2-[4-(morpholinomethyl)phenyl]-N-(2-pyrrolidin-1-ylethyl)quinoline-4-carboxamide 6-Fluoro-2-[4-(4-morpholinylmethyl)phenyl]-N-[2-(1-pyrrolidinyl)ethyl]-4-quinolinecarboxamide 4-Quinolinecarboxamide, 6-fluoro-2-[4-(4-morpholinylmethyl)phenyl]-N-[2-(1-pyrrolidinyl)ethyl]- CAS 1469439-69-7 CAS 1469439-71-1 SUCCINATE MF C27H31FN4O2 MW 462.559043 g/mol 6-fluoro-2-[4-(morpholin-4-ylmethyl)phenyl]-N-(2-pyrrolidin-1-ylethyl)quinoline-4-carboxamide Originator Medicines for Malaria Venture; University of Dundee Class Small molecules Mechanism of Action Protein synthesis inhibitors Highest Development Phases No development reported Malaria Most Recent Events 16 Jul 2016 No recent reports of development identified for preclinical development in Malaria in …